Share on StockTwits

Cempra Holdings (NASDAQ:CEMP) issued its quarterly earnings data on Tuesday. The company reported ($0.51) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.48) by $0.03, American Banking News reports. The company had revenue of $3.10 million for the quarter, compared to the consensus estimate of $2.10 million.

Shares of Cempra Holdings (NASDAQ:CEMP) traded up 0.64% on Tuesday, hitting $9.37. The stock had a trading volume of 324,180 shares. Cempra Holdings has a 52-week low of $6.01 and a 52-week high of $15.39. The stock’s 50-day moving average is $10.62 and its 200-day moving average is $11.96. The company’s market cap is $311.0 million.

On a related note, analysts at Barclays initiated coverage on shares of Cempra Holdings in a research note on Tuesday, April 8th. They set an “equal weight” rating and a $13.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $15.63.

Cempra, Inc, formerly Cempra Holdings, LLC, is a development-stage and clinical-stage pharmaceutical company focused on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.